%D8%B3%D9%84%D9%81%D8%A7%D8%AF%D9%88%D9%83%D8%B3%D9%8A%D9%86SylffadocsinSulfadoxinSulfadoxineSulfadoxina%D8%B3%D9%88%D9%84%D9%81%D8%A7%D8%AF%D9%88%DA%A9%D8%B3%DB%8C%D9%86SulfadoksiiniSulfadoxineSulfadossinaSulfadoksynaSulfadoxin%C4%83SulfadoksinSulfadoksin%D0%A1%D1%83%D0%BB%D1%8C%D1%84%D0%B0%D0%B4%D0%BE%D0%BA%D1%81%D0%B8%D0%BDQ411557%E7%A3%BA%E8%83%BA%E5%A4%9A%E8%BE%9B
about
Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-PyrimethamineAntimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria TransmissionArtesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax MalariaEfficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese ChildrenACT MALI: Treatment of Malaria Based on Combination TherapiesIPT of Malaria With SP in Different Zones of Drug Resistance in RwandaEvaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In AfricaMass-Drug Administration to Reduce Malaria TransmissionIntermittent Preventive Treatment With Antimalarials in Kenyan InfantsAzithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast AsiaChloroquine for Malaria in PregnancyPharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc)Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in MalawiArtesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum MalariaIntermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New GuineaSeasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in GhanaEvaluation of the Public Health Impact of Seasonal Intermittent Preventive Treatment (IPT) in Children in SenegalDaily Co-trimoxazole Prophylaxis to Prevent Malaria in PregnancyA Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the SudanImpact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in SchoolchildrenSPK Study in AfghanistanEfficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in KenyaSulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in UgandaIntermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in PregnancyA Randomized Controlled Trial for Intermittent Preventive Treatment in Pregnancy With Fansidar in Solomon IslandsTrial of Artesunate Combination Therapy in PakistanChemopreventive Therapy for Malaria in Ugandan ChildrenDihydroartemisinin (DHA)-Piperaquine for IPT to Prevent Malaria in Children in Burkina FasoIntermittent Preventive Treatment for Malaria in Infants in Navrongo GhanaEvaluation of Alternative Antimalarial Drugs for Malaria in PregnancyIntermittent Preventive Treatment in Infant in MaliNew Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural AfricaSeasonal Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine in Children in MaliA Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG WomenA Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ PatientsA Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + PatientsPackage of Interventions After Recovering From Moderate Acute MalnutritionA Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African ChildrenEfficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
P4844
High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in TanzaniaCombination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancySubstantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina FasoEfficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, ZambiaDeclining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern IndiaMolecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapyDecreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania.Chloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparumRandomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparumPrimaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunateHigh resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian childrenGlucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort StudyHealth facility-based data on women receiving sulphadoxine-pyrimethamine during pregnancy in Tanzania: lessons to learn from a cross-sectional survey in Mkuranga and Mufindi districts and other national survey reports.Efficacies of chloroquine, pyrimethamine/sulphadoxine and pyrimethamine/sulphalene against P. falciparum in northeastern Nigeria.Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of VanuatuMolecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Clinical malaria among pregnant women on combined insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine in Yaounde, Cameroon.Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa).Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.Determination of trimethoprim and sulphadoxine residues in porcine tissues and plasmaMonitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technologyAnti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycinIntermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malariaIntermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia.Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso.Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trialCoverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire.A study of toxicity and differential gene expression in murine liver following exposure to anti-malarial drugs: amodiaquine and sulphadoxine-pyrimethamine.High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese childrenEfficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in MaliEvaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
P921
Q61907790-6ED5A3FE-3457-44EB-B19F-8577CD3735DDQ61914369-F0854901-CCD1-4E3D-A614-A4606073CA5DQ61918402-DB1C2C54-08D5-4ACE-9C9E-5EA0F719830EQ61920760-EE549053-3F85-4AC0-9B32-EDC89711D36CQ61920835-65DD85F9-612B-43E2-A031-A0838C613507Q61932942-4CFB50E6-986A-4D6B-B699-7F00B4A85666Q61935835-6E8E9167-289D-488F-A7E5-BC4D645BA08BQ61979503-078D1389-567E-44D8-A2E3-26806876AD4FQ62105182-2042FDB9-9D52-4148-840A-6653C61BD965Q62110767-EB4150E0-45D0-4408-8442-320127A3C39EQ63322036-62D819B8-7E5F-4F18-AEEE-A85AB93FF476Q63338398-02821DDD-66FE-4AAB-B3C1-067F13BAFF54Q63400554-98A3305D-A099-40C5-A2DF-530642334E33Q63830354-6CBF064B-305C-4145-8416-05F04031DA5DQ63831778-0BBE5D42-F397-4938-9EBC-DD19830A4477Q63833680-CAAF3FDB-F53C-44CF-BFA7-6305CBF0BBC4Q63838502-BE2C75C3-AB38-4ABA-82EB-55599F1BAD6AQ64040449-52CB7A4A-0D4B-4D01-85CE-873BFDB26384Q64040547-DDA40EA9-A4BE-4614-97BB-6908D6399A23Q64216992-FD765553-112C-42F4-891F-C486B78A11BBQ64638140-820EE2DF-8C77-4410-B526-3943BA4E105BQ64639365-4C14F722-D6BD-4AD1-8054-496E92057F58Q64641955-4B6DDF49-933F-4EC6-916A-1D225DF7F4ABQ64653995-BF741D18-E833-4DB9-922D-C39ADF6C6C3AQ64655619-9E93AB48-87F7-49AD-8308-0A0FB6E67197Q64663194-76452F5A-B51D-46C1-9082-0EC2C32EE499Q64663961-4F29C632-8681-4356-AAE2-D4CEB61DF0D7Q64665176-75A5672F-4FAE-4EB8-8F2E-2515D5D7EF95Q64665716-28C87D96-AB7A-4D2A-B78B-45AEC0869853Q64679178-A8D6F485-0663-4039-908B-927EDA865745Q64697180-897C11A9-4BF2-4888-8EAE-3452131FAB0EQ64716506-4802AFB1-0827-497B-840E-BF9B06D1DF58Q64717890-25F1F605-676A-4AB0-B549-053D9CB8B50CQ64722525-5FCCA050-DF2D-4DEB-B8FF-7ABEDB88E335Q65317178-C2EEBE8D-F141-43A8-AD5F-69BAC7939A03Q65336640-5A472770-03C0-4D4E-BAF1-DDA834B43AD1Q65337776-FD8882D6-B7FB-4D06-B892-2F466DDB0EEDQ65350203-F0C30521-2006-42D5-A2F8-BB49A77A4757Q65352813-D5F2A6BE-0E16-43AF-8DB0-A14F47EC2B41Q65371015-103C8A99-BE2C-484E-A8E9-FA3862127152
P4844
Q21033803-11B152CE-969C-40FA-BBBE-810F939BD842Q27005614-8715BDAD-9F6D-403D-8D67-52A1528A8942Q28125898-123F5E0E-8E8F-418B-B3DE-583C1FA978BFQ28125905-FB659631-46BC-4B1A-94BA-75E98705FA74Q28125909-17A032AC-52B1-416C-90D6-B529FFE37602Q28125911-DBB6C482-D98D-4EE5-A397-BA1D32A38EFBQ28210310-7752E095-0EEC-4795-9333-9D7E48796CB7Q28469025-AE54DFA7-9D3B-4A2D-B8FD-C965B11C598FQ28469026-69F11401-20BE-4BA1-8874-22F1C3BB76ADQ28469316-A1832CCA-C7C9-47C1-B0BF-459014976329Q28474860-9D7C8F88-301C-4EB2-A631-98AADF5F39F0Q28475177-298C2AEE-887E-439E-BE4B-43BD0EAA7BD7Q28547654-C8686AE6-365E-453E-9382-8CC062A06B30Q30735248-95A0B218-AB9D-4FED-A15E-5ACB9031C2E0Q33198189-686A5392-FF8B-4295-AC49-FE53DE524AB0Q33549954-B2722530-5171-4B5B-B668-F0A14C7B1119Q33645358-11010B65-045D-4B73-B881-9CF37E6E1F29Q33687284-C1168576-3D24-48E8-A64C-FE44D17E6843Q33702580-B9306F98-6BE2-434E-9325-C9785C4ECA97Q33720539-762AD479-8233-46DE-AC91-86BD0684EA5EQ34014169-FD952732-9200-45C1-A367-B9EA0137FD47Q34071371-223684F5-7D7F-48D1-9632-DF02D4F95FC8Q34095327-A8E877B2-A5B6-49A1-8B97-A5C40E645000Q34221842-AE6C4A7D-B847-448E-945D-1C8845ADE596Q34322250-089598BB-2EA8-4BDD-BC55-78DD76F61775Q34372476-1C06D497-4400-4CCE-9581-F9EE4851EFEDQ34397470-600A6750-A09F-473D-A32E-46B85FE70673Q34402882-FBE07B22-8F20-4DF5-AA71-3A566DB3BEB5Q34410295-0DEC29BC-0EAB-4A29-996F-655B8B71C97AQ34416348-C34FC176-56C6-4F3A-8090-2BF97F3F3169Q34465026-5F2399AC-46C9-48E0-AAA9-904A22F2B1E8Q34579161-6BBCA6B3-C324-43FF-B297-743A47314F07Q34637039-B8AD7163-51A2-45EB-9111-F8346BE83272Q34944810-86001090-8D1A-4FE5-A09C-35A1E45FAC78Q35008674-C6484856-99B4-425D-A28E-FFCD638A8792Q35025311-EA94553A-7A9B-46C1-9387-970FB80365FEQ35038613-31D316F8-0DA0-4F27-8B8F-4614BD7CF6F3Q35038632-2A77CBC5-A81F-40C0-955A-21B5F9486DA4Q35078892-2E3C05C4-EB08-47E6-A5BE-BA8BC108A3AFQ35082469-36A98D8C-FF61-475E-8F4C-A0902005EE36
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Sulfadoksiini
@fi
Sulfadoksin
@sh
Sulfadoksin
@sr
Sulfadossina
@it
Sulfadoxin
@de
Sulfadoxina
@es
Sulfadoxine
@nl
Sulfadoxină
@ro
sulfadoksin
@nn
sulfadoksyna
@pl
type
label
Sulfadoksiini
@fi
Sulfadoksin
@sh
Sulfadoksin
@sr
Sulfadossina
@it
Sulfadoxin
@de
Sulfadoxina
@es
Sulfadoxine
@nl
Sulfadoxină
@ro
sulfadoksin
@nn
sulfadoksyna
@pl
altLabel
4-Sulfanilamido-5,6-dimethoxypyrimidine
@en
C12H14N4O4S
@it
Fanasil
@cy
Fanasil
@en
Fanzil
@cy
Fanzil
@en
Ro-44393
@cy
Ro-44393
@en
Sulfadoxina
@cy
Sulfadoxina
@en
prefLabel
Sulfadoksiini
@fi
Sulfadoksin
@sh
Sulfadoksin
@sr
Sulfadossina
@it
Sulfadoxin
@de
Sulfadoxina
@es
Sulfadoxine
@nl
Sulfadoxină
@ro
sulfadoksin
@nn
sulfadoksyna
@pl